Group 1 - The article presents the top 20 stocks in the S&P China A-Share Dividend Opportunity Index (CSPSADRP) based on their daily and year-to-date performance as of December 25, 2025 [1][5] - The top performer, Xin'ao Co., Ltd. (603888.SH), recorded a daily increase of 3.78% and a year-to-date increase of 19.40%, with a dividend yield of 3.91% [1][5] - De'ye Co., Ltd. (605117.SH) showed a significant year-to-date increase of 55.09%, with a daily increase of 3.58% and a dividend yield of 3.41% [1][5] Group 2 - The list includes companies with varying year-to-date performances, such as Lurui Co., Ltd. (002083.SZ) with a remarkable increase of 145.17% despite a daily increase of only 2.02% [1][5] - Other notable mentions include Tianshan Aluminum Industry (002532.SZ) with a year-to-date increase of 97.57% and Jiangsu Jinzu (600901.SH) with a dividend yield of 6.57% [1][5] - The data indicates a mix of performance across different sectors, highlighting investment opportunities in dividend-paying stocks [1][5]

Core Viewpoint - The Chinese home furnishing industry is at a historical crossroads in 2025, facing declining housing demand due to demographic changes and urbanization slowdown, leading to a downturn in traditional home furnishing consumption reliant on the real estate cycle [1] Group 1: Industry Overview - In the first 11 months of 2025, national real estate development investment decreased by 15.9% year-on-year, and personal mortgage loans fell by 15.1%, indicating a tightening funding chain impacting the home furnishing and building materials sector [1] - The home furnishing industry, which thrived on real estate benefits for two decades, is now entering a phase of competition over existing stock [1] Group 2: Company Strategy - Mousse Co., as a leader in the healthy sleep sector, has chosen a challenging yet correct path by seeking growth through global market expansion via acquisitions and brand output, rather than engaging in domestic price competition [3][4] - Mousse's revenue for the first three quarters of 2025 was 3.761 billion yuan, a slight decrease of 3.01% year-on-year, with net profit down by 10.61% to 467 million yuan [4] Group 3: Strategic Transformation - Mousse's acquisition of Singaporean home furnishing company MIPL for approximately 248 million yuan marks a significant strategic shift, allowing Mousse to gain localized production capabilities in Southeast Asia [5] - The Southeast Asian mattress market is projected to reach approximately 3.3 billion USD, driven by a large young population and a growing middle class [6] Group 4: Technological Innovation - Mousse's collaboration with Huawei's HarmonyOS has led to the launch of the HarmonyOS Smart Bed series, which integrates various smart home devices for a seamless user experience [11][12] - The sales of Mousse's AI smart mattresses exceeded 100 million yuan, with an increase in online unit prices reaching 15,000 to 20,000 yuan, indicating a willingness among high-net-worth individuals to invest in technologically advanced health solutions [12][14] Group 5: Future Outlook - Mousse is attempting to transform the home furnishing business model from low-frequency purchases to high-frequency, long-cycle health services, with AI product revenue growing over threefold in the first half of 2025 [14] - The company is positioned to navigate the challenges of the home furnishing industry, showcasing how a traditional manufacturing entity can seek certainty amid uncertainty [14]

DeRUGEL慕思集团 s and on 147 P fil n in the 影音音音 Portifica Province Pro BOOKER - - DeRUCCI *思集团 。 研究中国内容 包括网络电视剧 中国 (高原台) -- 酮糖厨期 | 미터키킨티 WWW WANE DeRUCCI 慕思集团 DeRUCCI 慕思集团 智引睡眠科技 falle 中华人民共和国教育部环境健康国际合作联 中华人民共和国教育部环境健康国际合作联合实验室智 揭牌仪式 日東4 司教育部 12月25日，慕思集团联合中山大学公共卫生学院、广东产品质量监督检验研究院、广东省钟南山医学基金会，正式揭牌成立"中华人民共和国教育部环境健 康国际合作联合实验室共建单位"暨"智慧健康睡眠生态系统研发基地"。此次合作将聚焦睡眠环境与健康交互研究，依托学术科研推动建立科学的行业标准 体系，为大健康产业提供科研与标准双重支撑，构建"产学研检"合作新范式。 ...

Group 1 - Guangqi Technology's controlling shareholder proposed a share buyback of 50 million to 100 million yuan for employee stock ownership plans or equity incentives [1] - Xingyuan Zhuomai received a supplier designation from a domestic electric vehicle manufacturer to develop and supply reducer shell components, with expected sales of approximately 575 million yuan over four years from 2027 to 2030 [2] - Weigao Bio's application for clinical trials of subcutaneous human immunoglobulin has been accepted by the National Medical Products Administration, targeting primary immunodeficiency diseases [3] Group 2 - Hongda Electronics disclosed uncertainty regarding the IPO progress of its associate Jiangsu Zhanxin, in which it holds a 13.79% stake [4] - Kangchen Pharmaceutical received FDA approval to conduct clinical trials for its KC1086 project, aimed at treating advanced recurrent or metastatic solid tumors [5] - Kweichow Moutai adjusted its share buyback price ceiling to 1863.67 yuan per share, effective from December 19, 2025 [6] Group 3 - Mousse Co. announced that its controlling shareholder and actual controllers committed not to reduce their holdings within one year [7] - Tongxingbao's subsidiary signed a business contract worth 43.166 million yuan for a cloud expansion project [8] - Kaifa Electric announced plans for three shareholders to collectively reduce their holdings by 0.6999% [9] Group 4 - Longpan Technology plans to increase the production capacity of lithium iron phosphate cathode materials from 62,500 tons per year to 100,000 tons per year [10] - Zhuhai Guanyu announced plans for two shareholders to reduce their holdings by up to 3% [11] - Jiaheng Home Textiles is planning a change in control, leading to a temporary suspension of its stock [12] Group 5 - Kehua Bio's subsidiary received a medical device registration certificate for a gene polymorphism detection kit [13] - Saitex New Materials' actual controller plans to reduce holdings by up to 3% [14] - Sanhui Electric announced a shareholder's plan to reduce holdings by up to 2% [15] Group 6 - Binhua Co. plans to establish a venture capital fund with a total scale of 400 million yuan, focusing on strategic emerging industries [16] - Jindun Co. announced plans for two shareholders to reduce their holdings by up to 4% [17] - Hengdian East Magnetic's controlling shareholder plans to reduce holdings by up to 1% [18][19] Group 7 - Luxin Investment's controlling shareholder plans to reduce holdings by up to 1% [20] - Huakang Clean announced a joint bid for a hospital procurement project worth 157 million yuan [21] - Xuedilong plans to reduce its repurchased shares by up to 488,560 shares [22] Group 8 - Enhua Pharmaceutical's subsidiary signed an exclusive commercial cooperation agreement for three long-acting antipsychotic products [23] - Aier Eye Hospital plans to acquire partial equity in 39 institutions for a total of 963 million yuan [24] - Gaozheng Mining plans to acquire 100% equity of Overseas Explosives for 510 million yuan [25] Group 9 - Donghong Co. plans to repurchase shares worth 30 million to 60 million yuan for employee stock ownership plans [26] - Bear Electric's controlling shareholder plans to reduce holdings by up to 0.64% [27] - *ST Zhengping announced the initiation of pre-restructuring by the Xining Intermediate Court [28][29] Group 10 - Caesar Travel's shareholder plans to reduce holdings by up to 3% [30] - Lianchuang Electronics announced a change in controlling shareholder to Jiangxi State-owned Assets Supervision and Administration Commission [31] - Beixin Road and Bridge plans to transfer 5.33% equity in Henan Yuhang for 243 million yuan [32] Group 11 - Fenglong Co. is planning a change in control, with stock resuming trading [33]

大家早上壕！ 先看海外要闻： 200亿收购AI芯片初创Groq？英伟达否认：只是达成推理技术许可。 OpenAI考虑在ChatGPT内植入广告。 报道：三星、SK海力士上调明年HBM3E价格，涨幅近20%。 报道：三星电子放缓DDR4停产进程，将与客户签署不得取消或更改的长期协议。 马斯克预测美国经济18个月内实现两位数增长，AI成关键驱动力。 赛诺菲拟22亿美元收购美国疫苗商Dynavax，加码成人疫苗布局。 俄罗斯计划未来十年在月球建成核电站。 国内重大事件汇总： 美股5连阳，道指收涨0.6%、纳指收涨0.22%、标普500收涨0.32%；苹果、Meta、微软、亚马逊至多收涨0.53%，特斯拉、谷歌A、英伟达则至多 收跌0.32%。 美国上周首申21.4万人，较前值小幅回落。 点评：国泰海通证券认为，数字人民币解决了传统跨境支付效率慢、成本高、安全性受限等问题，且我国移动支付生态成熟，微信支付、支付宝 占据90%以上第三方支付市场，为数字人民币推广提供天然优势。随着国际运营中心落地，三大业务平台将构建安全高效的跨境支付"中国方 案"，2030年跨境支付场景下数字人民币交易规模乐观预期可达162.4万亿元。 ...

Group 1 - On December 25, a total of 8 companies had their restricted shares unlocked, with a total unlock volume of 247 million shares, amounting to a market value of 6.273 billion yuan based on the latest closing price [1] - The companies with the highest unlock volumes were Mousse Co., Ltd., Shengda Biology, and Guangdong Hongda, with unlock shares of 222 million, 17.84 million, and 4.4287 million respectively [1] - In terms of unlock market value, Mousse Co., Ltd., Shengda Biology, and Guangdong Hongda led with market values of 5.721 billion yuan, 304 million yuan, and 182 million yuan respectively [1] Group 2 - The companies with the highest unlock ratios relative to their total share capital were Mousse Co., Ltd., Shengda Biology, and Keda Control, with unlock ratios of 50.92%, 9.44%, and 1.42% respectively [1]

每经AI快讯，数据显示，周四（12月25日），共有8家公司限售股解禁，合计解禁量为2.47亿股，按最 新收盘价计算，合计解禁市值为62.73亿元。 从解禁量来看，慕思股份、圣达生物、广东宏大解禁量居前，解禁股数分别为2.22亿股、1784.07万股、 442.87万股。 从解禁市值来看，慕思股份、圣达生物、广东宏大解禁市值居前，解禁市值分别为57.21亿元、3.04亿 元、1.82亿元。 从解禁股数占总股本比例来看，慕思股份、圣达生物、科达自控解禁比例居前，解禁比例分别为 50.92%、9.44%、1.42%。 ...

一、承诺股东基本情况 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：001323 证券简称：慕思股份 公告编号：2025-076 慕思健康睡眠股份有限公司关于控股股东、实际控制人自愿承诺不减持公司股份的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 慕思健康睡眠股份有限公司（以下简称"公司"）于近日收到公司控股股东东莞市慕腾投资有限公司（以 下简称"慕腾投资"）及实际控制人王炳坤先生、林集永先生出具的《关于自愿不减持公司股份的承诺 函》。现将相关情况公告如下： 四、备查文件 控股股东慕腾投资及实际控制人王炳坤先生、林集永先生分别出具的《关于自愿不减持慕思健康睡眠股 份有限公司股份的承诺函》。 特此公告。 慕思健康睡眠股份有限公司 董事会 2025年12月25日 截至本公告披露日，上述承诺股东最近十二个月未减持公司股份。 二、此次承诺的主要内容 公司控股股东慕腾投资及实际控制人王炳坤先生、林集永先生自愿承诺：基于对公司未来发展前景的信 心以及长期投资价值的认可，同时为增强广大投资者信心，切实维护投资者权益和资本市场稳定，其自 所持有的公司首次 ...

Core Viewpoint - Mousse Health Sleep Co., Ltd. announced that its controlling shareholder, Dongguan Muten Investment Co., Ltd., and actual controllers Wang Bingkun and Lin Jiyong, have issued a commitment letter to voluntarily not reduce their shareholdings for 12 months, reflecting confidence in the company's future development and a commitment to market stability [1][4]. Group 1: Commitment Details - The commitment period is from December 25, 2025, to December 24, 2026, during which the shareholders will not reduce their holdings in any form [4]. - The commitment applies to all shares held directly by the shareholders, including any new shares resulting from capital increases or stock dividends during this period [4]. - The shareholders have not reduced their holdings in the past twelve months [3]. Group 2: Shareholder Information - Dongguan Muten Investment is the largest shareholder, holding 165 million shares, which accounts for 37.92% of the total share capital of Mousse Health [2]. - Wang Bingkun serves as the Chairman and General Manager, while Lin Jiyong is a board member, both being the actual controllers of the company [2]. Group 3: Board Oversight - The board of Mousse Health will continuously monitor the fulfillment of the commitment by the controlling shareholder and actual controllers, ensuring compliance with relevant laws and regulations [6]. - The market views the voluntary extension of the share lock-up commitment as a positive signal for the company's long-term development, which may help stabilize market expectations and enhance investor confidence [6].

格隆汇12月24日丨慕思股份(001323.SZ)公布，近日收到公司控股股东东莞市慕腾投资有限公司（简 称"慕腾投资"）及实际控制人王炳坤先生、林集永先生出具的《关于自愿不减持公司股份的承诺函》。 公司控股股东慕腾投资及实际控制人王炳坤先生、林集永先生自愿承诺：基于对公司未来发展前景的信 心以及长期投资价值的认可，同时为增强广大投资者信心，切实维护投资者权益和资本市场稳定，其自 所持有的公司首次公开发行前已发行股份上市流通之日起12个月内（即2025年12月25日至2026年12月24 日），不以任何形式减持直接持有的公司股份。在上述承诺期间，如发生资本公积转增股本、派送股票 红利、配股等产生新增股份的情形，亦遵守该不减持承诺。若违反上述承诺，则减持股份所得全部收益 （如有）归公司所有。 ...